NCT00029822

Clinical Trial in Males With BPH (Enlarged Prostate)

Long-Term, Efficacy and Safety of Alfuzosin 10 MG OD on the Risk of Acute Urinary Retention and the Need for Surgery in Patients With BPH. A Two Year, Randomized, Multicenter, Double-Blind, Parallel Group, Placebo-Controlled Study.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 1,522 (actual)
• Sponsor: Sanofi · Industry
• Sex: Male
• Age: 55 Years
• Healthy volunteers: Not accepted

Summary

A study to determine the effect on prevention of Acute Urinary Retention (inability to urinate) in males with an enlarged prostate, also known as BPH. * Free study-related medical care provided.

Conditions

• Urinary Retention
• Prostatic Hyperplasia
• Benign Prostatic Hypertrophy

Interventions

Type	Name	Description
DRUG	Alfuzosin (SL770499)

Timeline

• Start date: 2001-05-01
• Completion: 2005-03-01
• First posted: 2002-01-24
• Last updated: 2008-06-09

Locations

54 sites across 17 countries: United States, Australia, Bulgaria, Canada, Denmark, Finland, Greece, Hungary, Israel, Netherlands, Norway, Poland, Portugal, Romania, South Africa, Spain, Sweden